Scholar Rock Holding Corp logo

Scholar Rock Holding Corp

SRRK
Healthcare|Biotechnology|USA
$56.75
-1.26 (-2.17%)
Tangible Book
$2.32
Earnings Power
$2.96

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 6.86, 152.06, 366.85, 544.66, 811.42 ], "ebit_estimate": [ -424.07, -330.46, -172.87, -32.66, 216.03 ], "ebitda_estimate": [ -413.83, -308.44, -127.82, null, null ], "net_income_estimate": [ -404.42, -332.95, -181.88, 44.11, 208.37 ], "per_share_eps_estimate": [ -3.22, -2.49, -1.37, 0.18, 1.54 ], "eps_nri_estimate": [ -3.21, -2.51, -1.32, 0.32, 1.51 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 2.06, 2.12, 1.71, null, null ], "pretax_income_estimate": [ -402.41, -338.08, -181.08, -20.18, 215.53 ], "operating_cash_flow_per_share_estimate": [ -2.87, -1.72, -0.78, null, null ], "roa_estimate": [ -58.1, -88.1, -69.6, null, null ], "roe_estimate": [ -222.98, -706.08, 31.09, null, null ], "gross_margin_estimate": [ 86.6, 88, 88.2, 89, 89.67 ], "operating_cash_flow_estimate": [ -365.29, -219.34, -98.64, null, null ], "pettm_estimate": [ 0, 0, 0, 315.28, 36.85 ], "long_term_growth_rate_mean": 25.86, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 24.98, "future_eps_nri_estimate_growth": 25.86, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 23.27, "future_ebitda_estimate_growth": 30.14, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 21.25, "future_pretax_income_estimate_growth": 21.19, "future_book_value_per_share_estimate_growth": -7.9, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.54, "future_operating_cash_flow_per_share_estimate_growth": 34.03 }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, 1.87, 5.62, 17.16, 26.07, 59.89, 83.5, 84.62 ], "ebit_estimate": [ -105.93, -110.85, -97.1, -113.85, -102.48, -94.17, -80.1, null ], "ebitda_estimate": [ -106.94, -113.94, -65.35, null, null, null, null, null ], "net_income_estimate": [ -106.67, -111.88, -108.14, -119.72, -108.35, -100.05, -85.97, null ], "per_share_eps_estimate": [ -0.85, -0.85, -0.78, -0.65, -0.61, -0.45, -0.43, null ], "eps_nri_estimate": [ -0.84, -0.85, -0.78, -0.72, -0.67, -0.54, -0.49, -0.4 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -106.45, -111.65, -84.39, -119.72, -108.35, -100.05, -85.97, null ], "operating_cash_flow_per_share_estimate": [ -0.84, -0.86, -0.86, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 88, 87.67, null, null, null, null, null ], "operating_cash_flow_estimate": [ -106.91, -109.46, -109.46, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 25.86, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 24.98, "future_eps_nri_estimate_growth": 25.86, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 23.27, "future_ebitda_estimate_growth": 30.14, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 21.25, "future_pretax_income_estimate_growth": 21.19, "future_book_value_per_share_estimate_growth": -7.9, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.54, "future_operating_cash_flow_per_share_estimate_growth": 34.03 }

News

2026-06-22 13:00:16
2026-06-12 21:00:06